Dilpreet Kaur

A rationally designed PE/PPE-based multi-epitope vaccine candidate engaging TLR4 to induce balanced humoral and cellular immunity against Mycobacterium tuberculosis

TB is a serious health challenge globally, with more than 10 million new cases every year and rising MDR and XDR variants diminishing the efficacy of existing chemotherapeutics. Although BCG vaccination confers protection in children, its limited ability to prevent adult pulmonar...